Hagen Casper P, Sørensen Kaspar, Mieritz Mikkel G, Johannsen Trine Holm, Almstrup Kristian, Juul Anders
Department of Growth and Reproduction, EDMaRC, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
J Clin Endocrinol Metab. 2015 May;100(5):1920-6. doi: 10.1210/jc.2014-4462. Epub 2015 Feb 19.
Puberty is initiated by a complex interaction of suppressing and stimulating factors. Genetic studies of familial central precocious puberty have suggested makorin ring finger protein 3 (MKRN3) as a major inhibitor of GnRH secretion during childhood. Furthermore, genetic variation near MKRN3 (rs12148769) affects age at menarche in healthy girls.
The purpose of this study was to evaluate whether serum levels of MKRN3 declined before pubertal onset in healthy girls.
This was a population-based longitudinal study of healthy Danish girls and a cohort study of early maturing girls.
The study was performed in the general community and in a tertiary referral center for pediatric endocrinology.
Healthy girls (n = 38) aged 9.3 years (range, 5.9-11.3 years) at baseline and followed for 6.0 years (2.7-7.6 years) (2006-2014) with blood sampling every 6 months and early maturing girls (n = 13) with breast development ay <8.3 years of age were included.
Serum levels of MKRN3 were measured in 354 samples (median, 9 per girl; range, 2-14 per girl), and genotyping of variants near MKRN3 (rs12148769 and rs12439354) was performed.
MKRN3 concentrations declined preceding pubertal onset; the geometric mean (95% confidence interval) 3 years before pubertal onset vs the last visit before pubertal onset was 304 pg/mL (264-350 pg/mL) vs 257 pg/mL (243-273 pg/mL), corresponding to a reduction of 15% (1-27%) (P = .033). In prepubertal girls, circulating MKRN3 correlated negatively with gonadotropin levels: for FSH, r = -0.262 (P = .015) and for LH, r = -0.226 (P = .037). After adjustment, MKRN3 levels were lower in early maturing girls than in age-matched prepubertal girls: 171 pg/mL (<25-333 pg/mL) vs 262 pg/mL (94-624 pg/mL) (P = .051). Genetic variants near MKRN3 did not correlate with serum levels of MKRN3.
Declining levels of circulating MKRN3 preceded pubertal onset. The negative correlation between MKRN3 and gonadotropins further supports MKRN3 as a major regulator of hypothalamic GnRH secretion during childhood. Undetectable or low MKRN3 levels were observed in a subgroup of patients with early onset of puberty.
青春期由抑制和刺激因素的复杂相互作用引发。家族性中枢性性早熟的遗传学研究表明,马克罗林环指蛋白3(MKRN3)是儿童期促性腺激素释放激素(GnRH)分泌的主要抑制剂。此外,MKRN3附近的基因变异(rs12148769)影响健康女孩的初潮年龄。
本研究旨在评估健康女孩青春期开始前血清MKRN3水平是否下降。
这是一项基于人群的健康丹麦女孩纵向研究以及早熟女孩队列研究。
研究在普通社区和一家儿科内分泌三级转诊中心进行。
纳入基线时年龄为9.3岁(范围5.9 - 11.3岁)、随访6.0年(2.7 - 7.6年)(2006 - 2014年)且每6个月采血一次的健康女孩(n = 38),以及8.3岁前乳房发育的早熟女孩(n = 13)。
检测354份样本(中位数,每位女孩9份;范围,每位女孩2 - 14份)中的血清MKRN3水平,并对MKRN3附近的变异(rs12148769和rs12439354)进行基因分型。
青春期开始前MKRN3浓度下降;青春期开始前3年与青春期开始前最后一次访视时的几何均值(95%置信区间)分别为304 pg/mL(264 - 350 pg/mL)和257 pg/mL(243 - 273 pg/mL),相当于降低了15%(1 - 27%)(P = 0.033)。在青春期前女孩中,循环MKRN3与促性腺激素水平呈负相关:对于促卵泡生成素(FSH),r = -0.262(P = 0.015);对于促黄体生成素(LH),r = -0.226(P = 0.037)。调整后,早熟女孩的MKRN3水平低于年龄匹配的青春期前女孩:171 pg/mL(<25 - 333 pg/mL)对262 pg/mL(94 - 624 pg/mL)(P = 0.051)。MKRN3附近的基因变异与MKRN3血清水平无相关性。
循环MKRN3水平在青春期开始前下降。MKRN3与促性腺激素之间的负相关进一步支持MKRN3是儿童期下丘脑GnRH分泌的主要调节因子。在一组青春期过早开始的患者中观察到MKRN3水平不可检测或较低。